2022
Exports
$1.05BWorld Rnk 3 / 157
Flag Rnk 423 / 1216
2022
PRODUCT COMPLEXITY IN Unpackaged Medicaments
0.61Rnk 312 / 1025
2022
Imports
$398MWorld Rnk 7 / 215
Flag Rnk 395 / 1212
2022
ECONOMIC COMPLEXITY of China
1.12Rnk 22 / 133

About

Exports In 2022, China exported $1.05B in Unpackaged Medicaments, making it the 3rd largest exporter of Unpackaged Medicaments in the world. At the same year, Unpackaged Medicaments was the 423rd most exported product in China. The main destination of Unpackaged Medicaments exports from China are: India ($153M), United States ($113M), Brazil ($70M), Hong Kong ($60.4M), and Japan ($45.7M).

The fastest growing export markets for Unpackaged Medicaments of China between 2021 and 2022 were India ($41.4M), United States ($27.8M), and Brazil ($22.9M).

Imports In 2022, China imported $398M in Unpackaged Medicaments, becoming the 7th largest importer of Unpackaged Medicaments in the world. At the same year, Unpackaged Medicaments was the 395th most imported product in China. China imports Unpackaged Medicaments primarily from: Switzerland ($103M), Germany ($79.1M), Sweden ($62.1M), Japan ($28.9M), and France ($20.9M).

The fastest growing import markets in Unpackaged Medicaments for China between 2021 and 2022 were Sweden ($59.5M), Germany ($54.4M), and Singapore ($17.5M).

COMPANIES In 2023, leading companies such as Jo-Ann Stores (2), Haas Automation (2), and Acer (1) were at the forefront of shipping Unpackaged Medicaments from China to the United States.

Latest Trends

September 2024

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (September 2023 - September 2024)$8M(9.33%)
IMPORT GROWTH (September 2023 - September 2024)$15.5M(63.3%)
MAIN EXPORTER (September 2024)Shandong Province$44.9M
MAIN DESTINATION (September 2024)India$23.2M

This section shows Unpackaged Medicaments's exports and imports data at subnational level for China. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Unpackaged Medicaments over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$1.05B
IMPORTS (2022)$398M
NET TRADE (2022)$653M

In 2022, China exported $1.05B in Unpackaged Medicaments. The main destinations of China exports on Unpackaged Medicaments were India ($153M), United States ($113M), Brazil ($70M), Hong Kong ($60.4M), and Japan ($45.7M).

In 2022, China imported $398M in Unpackaged Medicaments, mainly from Switzerland ($103M), Germany ($79.1M), Sweden ($62.1M), Japan ($28.9M), and France ($20.9M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Unpackaged Medicaments EXPORT MARKETS FOR China WERE (2021 - 2022):
India$41.4M (37%)
United States$27.8M (32.5%)
Brazil$22.9M (48.8%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Unpackaged Medicaments BY China WERE (2021 - 2022):
Indonesia-$7.6M (-34.2%)
Iran-$6.09M (-42.7%)
Austria-$4.63M (-30.8%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, China's main exporting competitors in Unpackaged Medicaments were:
In 2022, China's main importing competitors in Unpackaged Medicaments were:

Explore Visualizations

Trade Value of Unpackaged Medicaments by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $34.6M
TOP IMPORT POTENTIALIndia+ $16.8M

Unpackaged Medicaments’s highest export potential is United States. With an export gap of $34.6M.   Unpackaged Medicaments’s highest import potential is India with an import gap of $16.8M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with